Calidi Biotherapeutics (CLDI) Total Current Liabilities (2021 - 2026)
Calidi Biotherapeutics' Total Current Liabilities came in at $3.24 million for Q2 2026, down 39.5% from $5.35 million a year earlier.
Powered by 
Analysis
Calidi Biotherapeutics (CLDI) Total Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2025, Calidi Biotherapeutics' Total Current Liabilities was $3.94 million, down 58.6% from FY2024.
- Total Current Liabilities has declined in each of the last three years, though with a four-year compound annual growth rate of 75.9% (FY2021 to FY2025).
- Going back by year, Total Current Liabilities was $9.5 million in FY2024 (-7.2%), $10.23 million in FY2023 (-76.2%), $42.99 million in FY2022 and $410,985 in FY2021.
- The Q2 2026 figure represents the lowest quarterly Total Current Liabilities since Q3 2022.
- Year-over-year, Total Current Liabilities increased in 1 of the last seven quarters, with an average decline of 39.5%.
- The fastest year-over-year change in Total Current Liabilities over five years came in Q3 2023 (growth of 711.6%), and the weakest in Q4 2023 (a decline of 76.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 47.00 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 55.46 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 43.10 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 28.80 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -31.27 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 23.23 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 12.00 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 31.73 Bn |
| 10 | Calidi Biotherapeutics | 991,199.98 | -25.74 Mn | - | 3.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.24 Mn |
| Mar 31, 2026 | 3.84 Mn |
| Dec 31, 2025 | 3.94 Mn |
| Sep 30, 2025 | 5.19 Mn |
| Jun 30, 2025 | 5.35 Mn |
| Mar 31, 2025 | 5.43 Mn |
| Dec 31, 2024 | 9.50 Mn |
| Sep 30, 2024 | 11.58 Mn |
| Jun 30, 2024 | 13.05 Mn |
| Mar 31, 2024 | 14.95 Mn |
| Dec 31, 2023 | 10.23 Mn |
| Sep 30, 2023 | 10.87 Mn |
| Jun 30, 2023 | 8.18 Mn |
| Mar 31, 2023 | 6.62 Mn |
| Dec 31, 2022 | 42.99 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 373,661.00 |
| Mar 31, 2022 | 386,833.00 |
| Dec 31, 2021 | 410,985.00 |
| Sep 30, 2021 | 47,901.00 |
API Access
Calidi Biotherapeutics Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=CLDI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "CLDI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=CLDI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();